Daewoong Pharmaceutical Co.,Ltd sell "URSA"

Available as tablets, soft capsules and hard capsules in 25, 50, 100, 200, 250 and 300 mg strengths of UDCA (ursodeoxycholic acid), indicated for cholestasis (including PBC and PSC), viral hepatitis C, and gallstones. URSA improves liver function in chronic hepatitis patients and improves symptoms and histopathology in cholestasis patients; UDCA is the only drug approved by the US FDA for PBC.